Ceftriaxone-induced immune hemolytic anemia: a case report
Understanding the patient's medical history can provide critical information for the diagnosis of DIIHA, and effective management of DIIHA includes immediate discontinuation of suspected drugs, transfusion support, plasma exchange, and symptomatic medication.
Authors
- Angela Li (ORCID: https://orcid.org/0000-0002-2881-5557)
- Liaoyun Zhang (ORCID: https://orcid.org/0000-0002-3682-0516)
- Li Wang (ORCID: https://orcid.org/0000-0001-7340-416X)
- Gen Li (ORCID: https://orcid.org/0000-0003-0087-7796)
- Yongxian Jiang (ORCID: https://orcid.org/0000-0001-7834-5939)
- Bo Qin (ORCID: https://orcid.org/0000-0002-4283-4041)
Institutions
- Chengdu Medical College (CN)
- Chengdu Women's and Children's Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-04
- DOI
- https://doi.org/10.3389/fimmu.2025.1476563
- Citations
- 2
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 3.54